Cite

HARVARD Citation

    Macera, M. et al. (n.d.). DAA-based regimens in HBsAg/anti-HCV positive patients: The need to control HBV replication to avoid HBV reactivation. Digestive and liver disease. 49 (1), pp. e34-e35. [Online]. 
  
Back to record